Conference Dates
June 12 – 17, 2022
Abstract
Quantitative high-quality SARS-CoV-2 serotests that are easy-to-implement have been gaining great importance as means to characterize and monitor the magnitude of infection- or vaccine-induced immunity over time and are of particular interest for academic laboratories doing COVID-19 research or small diagnostic laboratories with basic equipment
Please click Download on the upper right corner to see the full abstract.
Recommended Citation
Miriam Klausberger, Mark Dürkop, Nikolaus Kienzl, Gerhard Stadlmayr, Lukas Mach, Gordana Wozniak-Knopp, and Reingard Grabherr, "Superior SARS-CoV-2 RBD antigen designs for highly specific, quantitative serotests" in "Vaccine Technology VIII", Tarit Mukhopadhyay, Merck Research Laboratories, USA; Charles Lutsch, Sanofi Pasteur, France; Linda Hwee-Lin Lua, University of Queensland, Australia; Francesc Godia, Universitat Autònoma de Barcelona, Spain Eds, ECI Symposium Series, (2022). https://dc.engconfintl.org/vaccine_viii/10